CAPGET (capecitabine ) is a
novel anti cancer drug which has a strong preference for certain
cancer cells, so much so that the healthy cells are affected to a
much lesser extent.
CAPGET (capecitabine ) is indicated in :
- Metastatic colorectal cancer as 1st line therapy
- Locally advanced or metastasic breast cancer after failure of
a taxane and an anthracycline- containing regimen